financetom
Business
financetom
/
Business
/
This Kerala boss thanked his employee of 22 years with a Merc worth Rs 45 lakh
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
This Kerala boss thanked his employee of 22 years with a Merc worth Rs 45 lakh
Feb 16, 2022 10:26 AM

There are bosses from hell like the Better.com CEO, who thought nothing of mass-firing staff via Zoom. And then there are dream bosses, like a Kerala retail store owner, who gifted a Mercedes-Benz SUV worth Rs 45 lakh to a long-time worker as a mark of appreciation.

Share Market Live

NSE

A.K. Shaji, who owns myG, gave his employee C.R. Anish a Benz GLA Class 220D. myG is an electronics and home appliances retail chain in Kerala. Anish has spent over two decades with the company and held various positions in marketing, maintenance and business development departments. Currently, Anish works as the Chief Business Development Officer in myG.

In a video posted to Instagram, Shaji praised his employee and said that Anish had been a "a pillar of support."

"Ani has been with me for the last 22 years even before I started myG. He is a strong pillar and a mainstay for me. He has never disappointed me. His brotherly affection and immense focus and dedication towards work supported me a lot. I consider Anish as a partner and not an employee,” Shaji said in the video.

Also read: Surat businessman continues his Santa Act, gifts employees 600 cars for Diwali

Shaji’s gesture was not a one-off thing. He had earlier gifted cars to six of his employees. He often sends his employees on expensive foreign trips.

Employers are becoming increasingly grateful towards their employees in the new era of work and corporate environments. Sara Blakely, Founder and CEO of shapewear firm Spanx, had surprised her employees with gifts of two first-class Delta Airlines plane tickets and $10,000 in cash to spend on their trip, in October 2021. The company was celebrating its $1.2-billion deal with private equity firm Blackstone.

(Edited by : Shoma Bhattacharjee)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Bausch Health Shares Down Nearly 45%
--Bausch Health Shares Down Nearly 45%
Jul 24, 2024
10:57 AM EDT, 07/24/2024 (MT Newswires) -- Price: 4.27, Change: -3.31, Percent Change: -43.66 ...
Chile's lower house of Congress asks Boric to void Codelco-SQM deal
Chile's lower house of Congress asks Boric to void Codelco-SQM deal
Jul 24, 2024
SANTIAGO, July 24 (Reuters) - Chile's lower house of Congress approved a resolution asking President Gabriel Boric to annul an agreement between state copper company Codelco and Chilean miner SQM that would give Codelco a prominent role in the lithium industry. The motion, passed late on Tuesday, was led by the Party for Democracy (PPD), part of the ruling coalition,...
Sage Therapeutics, Biogen Stop Development of Investigational Drug for Essential Tremor
Sage Therapeutics, Biogen Stop Development of Investigational Drug for Essential Tremor
Jul 24, 2024
10:58 AM EDT, 07/24/2024 (MT Newswires) -- Sage Therapeutics ( SAGE ) and Biogen (BIIB) said Wednesday that they will terminate a phase 2 trial of their investigational drug SAGE-324 and don't plan to further develop the drug in essential tremor. They said that based on topline results from the phase 2 study, SAGE-324 or BIIB124 did not show a...
Pieris Pharmaceuticals, Palvella Therapeutics Agree to Merge; Pieris Shares Jump
Pieris Pharmaceuticals, Palvella Therapeutics Agree to Merge; Pieris Shares Jump
Jul 24, 2024
10:59 AM EDT, 07/24/2024 (MT Newswires) -- Pieris Pharmaceuticals ( PIRS ) and Palvella Therapeutics said Wednesday they have agreed to merge in an all-stock transaction. The combined entity will focus on developing and marketing Palvella's QTORIN rapamycin, for treating skin diseases. Upon completion, the merged entity will operate as Palvella Therapeutics and is expected to trade on Nasdaq, according...
Copyright 2023-2026 - www.financetom.com All Rights Reserved